Fig. 1
From: The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
Time course changes in antibodies after 131I therapy. A and B Show time course changes in TRAb and TPOAb in Graves’ disease patients before and after 131I therapy. *denotes p < 0.05, ***denotes p < 0.001, ###p < 0.001 represents the 1–6 months group versus 13–60 months group and >60 months group, &&&p < 0.001 represents the 7–12 months group versus 13–60 months group and >60 months group, $$p < 0.01 represents the 13–60 months group versus >60 months group